Tracie Oliver

Chief Commercial Officer, Arrowhead Pharmaceuticals.

Companies

Arrowhead PharmaceuticalsChief Commercial Officer Jun 29, 2022 to Jul 3, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arrowhead Pharmaceuticals ARWR127,107 shares²$7.2M at $56.73Jul 2, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 2, 2024Sold 9,394 shares at $25.28 of Arrowhead Pharmaceuticals²
Jan 5, 2024Sold 74 shares at $33.89 of Arrowhead Pharmaceuticals³
Jan 4, 2024Granted 75,000 shares of Arrowhead Pharmaceuticals³
Jul 3, 2023Sold 8,925 shares at $35.31 of Arrowhead Pharmaceuticals⁴
Jan 4, 2023Granted 500 shares of Arrowhead Pharmaceuticals⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArrowhead Pharmaceuticals, Chief Commercial Officer
2
SEC EDGARArrowhead Pharmaceuticals shares after the filing of Jul 2, 2024
3
SEC EDGARForm 4 filed Jan 8, 2024
4
SEC EDGARForm 4 filed Jul 6, 2023
5
SEC EDGARForm 4 filed Jan 5, 2023